Completed Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma NCT03229278 Conditions Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more Locations Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States View Trial Details
Completed JAK-inhibition in Recurrent Classical Hodgkin Lymphoma NCT02164500 Conditions Recurrent Classical Hodgkin Lymphoma Locations 1st Dept. of Medicine, Cologne University Hospital — Cologne, Germany View Trial Details
